REVIEW article
Front. Cell. Infect. Microbiol.
Sec. Clinical Infectious Diseases
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1589653
This article is part of the Research TopicImmune Insights into Orthopedic Infections: Mechanisms, Biomarkers, and PreventionView all 7 articles
Biomaterials for Bone Infections: Antibacterial Mechanisms and Immunomodulatory Effects
Provisionally accepted- 1Liaoning University of Traditional Chinese Medicine, Shenyang, China
- 2Department of Laboratory Medicine, Shengjing Hospital of China Medical University, China/Shen-yang, China
- 3Innovative Engineering Technology Research Center for Cell Therapy, Shengjing Hospital of China Medical University,, Shenyang, China
- 4Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
As the global population continues to age, an increasing number of individuals suffer from osteoporosis, fractures, bone infections, and bone tumors. Among these, bone infection is considered one of the most challenging clinical infections due to its high recurrence rate, bacterial resistance, high incidence, and substantial treatment costs. However, these challenges underscore the urgent need for clinicians to develop novel therapeutic strategies to improve the current cure rate and reduce the mortality associated with bone infections. Current scientific research on bone infections primarily focuses on developing new antibacterial targets and infection-resistant biomaterials. In recent years, remarkable advancements have been made in anti-infective biomaterials, offering promising solutions to overcome bone infections. By optimizing the biological properties of biomaterials or integrating them with other materials, researchers aim to achieve maximum antibacterial efficacy and biocompatibility. Such advancements enhance the integration of biomaterials with soft tissues, improve interactions between bone cells and biomaterials, promote osteogenesis, and mitigate inflammatory responses. This review primarily focuses on exploring the antibacterial mechanisms of infection-resistant biomaterials and their regulatory effects on the immune system, with particular emphasis on nanoscale carriers, scaffolds, and particulate materials.
Keywords: bone infection, immune cells, Biomaterials, scaffolds, Macrophages
Received: 07 Mar 2025; Accepted: 30 Apr 2025.
Copyright: © 2025 Haoran, Li, Jin, Yan, Qu, Chen, Peng, Wang, Li and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Junying Li, Innovative Engineering Technology Research Center for Cell Therapy, Shengjing Hospital of China Medical University,, Shenyang, China
Yang Liu, Innovative Engineering Technology Research Center for Cell Therapy, Shengjing Hospital of China Medical University,, Shenyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.